Recent Advances and Trends in Ophthalmic Diseases Treatment
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biofabrication and Biomanufacturing".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 2795
Special Issue Editor
Interests: ophthalmology; cataract surgery; cornea
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue "Recent Advances and Trends in Ophthalmic Diseases Treatment" explores the latest advancements, trends, and innovations in the field of ophthalmology. This Special Issue aims to provide a comprehensive overview of the recent developments in diagnostic tools, therapeutic approaches, and surgical techniques for various ophthalmic diseases.
The Special Issue begins by discussing the recent progress in the diagnosis of ophthalmic diseases, including advancements in imaging technology, genetic testing, and biomarker identification. It explores novel diagnostic approaches that enable earlier detection and more accurate assessment of disease progression.
The Special Issue highlights the latest therapeutic approaches for ophthalmic diseases, ranging from traditional pharmacotherapy to emerging modalities such as gene therapy and regenerative medicine. It emphasizes the development of targeted therapies and personalized treatment strategies based on specific disease subtypes.
Furthermore, the Special Issue explores recent advances in surgical techniques for ophthalmic diseases, including minimally invasive procedures, robotic-assisted surgery, and advanced intraocular devices. It discusses innovations that enhance surgical precision, improve patient outcomes, and minimize post-operative complications.
It also addresses the integration of artificial intelligence (AI) and machine learning in ophthalmology, including AI-based algorithms for disease classification, automated image analysis, and predictive modeling.
Overall, this Special Issue aims to provide insights into the recent advances and trends in ophthalmic disease treatment. The research within this Special Issue contributes to the improvement of diagnostic accuracy, development of innovative therapies, and enhancement of surgical techniques, ultimately leading to better outcomes for patients with ophthalmic conditions.
Dr. Kim Jae Yong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ophthalmic diseases
- diagnosis
- therapeutic approaches
- surgical techniques
- pharmacotherapy
- regenerative medicine
- imaging technology
- artificial intelligence
- precision medicine
